ANALISIS PENGGUNAAN GLIBENKLAMID DAN GLIMEPIRID BERDASARKAN PERESEPAN OBAT MENGGUNAKAN METODE ATC/DDD)
DOI:
https://doi.org/10.30649/pst.v3i1.32Keywords:
Glibenclamide, Glimepirid, ATC/DDDAbstract
Diabetes Mellitus is a non-contagious disease in which insulin cannot be produced optimally by the pancreas, characterized by hyperglycemia. Glibenclamide and glimepiride are sulfonylurea antidiabetic drugs. To analyze the use of Glibenclamide and Glimepirid drugs at the Sekupang Public Health Center in 2020 using the ATC/DDD method. The result of DDD/1000 KPRJ/Day Glibenclamide 5 mg was 10.29 mg for the highest on April, and the lowest was 0.57 mg on February. The one-year average was 2.97 mg. The result of DDD//1000 OPV/Day Glimepiride 2 mg was 16.80 mg is the highest on February, and the lowest was 2.79 mg on June. The one-year average was 6.77 mg. The results of DDD/1000 KPRJ/Day Glimepiride 4 mg were highest on October 23,48 mg, and the lowest was on January 3.45 mg, with 13.15 mg average per year. The one-year average of DDD value of Glibenclamide 5 mg does not surpass the 10 mg WHO DDD value, so it can be concluded that the use of Glibenclamide has not been widely used in the community. For Glimepiride 2 mg and 4 mg, the DDD value obtained exceeds the WHO DDD value of 2 mg, it can be concluded that Glimepirid is widely used in the community.
Downloads
References
Punthakee, Z., Goldenberg, R., & Katz, P. 2018. Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome. Canadian Journal of Diabetes, 42,S10–S15.
American Diabetes Association. 2020. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care, 43(January), S14–S31.
Depkes RI. 2005. Pharmaceutical Care untuk Penyakit Diabetes Mellitus. Departemen Kesehatan RI.
Dipiro, T. J., Talbert, L. R., Yee, C. G., Matzke, R. G., Wells, G. B., & Posey, M. L. 2008. Geriatrics. In Management of Laparoscopic Surgical Complications.
Anjarwati, D., & Putri, A. R. 2013. Gambaran Penggunaan Obat Antidiabetik Oral di Puskesmas Slawi Kabupaten Tegal. 09, 1–6.
Agustin, R. S. 2019. Gambaran Peresepan Penggunaan Obat Anti Diabetes Melitus Pada Pasien Rawat Jalan di Puskesmas Teladan Kota Medan Tahun 2019. 53(9), 1689–1699.
Furman, B. 2016. Glibenclamide. January, 1–4.
Basit, A., Riaz, M., & Fawwad, A. 2012. Glimepiride: Evidence-Based Facts, Trends, and Observations. Vascular Health and Risk Management, 8(1), 463–472.
Trerattanavong, K., & Tadi, P. 2021. Glimepiride. [Updated 2021 Jan 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. 1–6.
WHO. 2021. Guidelines for ATC Classification and DDD Assignment. WHO Collaborating Centre for Drug Statistics Methodology, 24.
Kemenkes RI. 2017. Petunjuk Teknis Evaluasi Penggunaan Obat Di Fasilitas Kesehatan Di Fasilitas,Kementerian Kesehatan RI, Jakarta. 16–17
Hardin, M., & Jacobs, T. 2020. Glyburide. [Updated 2020 May 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan.
Hadiwiardjo, K. Y. dan. 2020. Perbandingan Penggunaan Glibenclamid-Metformin dan Glimepirid-Metformin Terhadap Efek Samping Hipoglikemia Pasien Diabetes Melitus Tipe-2 di Kota Tangerang Selatan Bulan Januari–Oktober Tahun 2019. Seminar Nasional Riset Kedokteran, 4(2), 147–154
Udayani, N. N. W., & Meriyani, H. 2016. Perbedaan Efektivitas Penggunaan Obat Antidiabetik Oral Tunggal Dengan Kombinasi Pada Pasien Dm Tipe 2 Di Upt. Puskesmas Dawan Ii Kabupaten Klungkung Periode November 2015-Pebruari 2016. Jurnal Ilmiah Medicamento, 2(2), 47–52.
Lahiry, S., Kundu, A., Mukherjee, A., Choudhury, S., & Sinha, R. 2017. Analyzing Antidiabetes Drug Prescriptions With World Health Organization Anatomical Therapeutic Chemical/Defined Daily Dose Index to Assess Drug Utilization Pattern in Elderly Population of Rural Eastern India. Integrative Medicine Insights, 8.
Mei, P. J., Poluan, O. A., Wiyono, W. I., & Yamlean, P. V. Y. 2020. DIABETES DI RUMAH SAKIT GUNUNG MARIA TOMOHON Program Studi Farmasi FMIPA UNSRAT Manado , 95115 Interaksi obat – obat merupakan kejadian interaksi obat yang dapat terjadi bila penggunaan bersama dua macam obat atau lebih ( Katzung , 2007 ). Interaksi obat . 9(1), 38–46.
Rahayuningsih, N., Alifiar, I., & Muryani, E. S. 2017. Evaluasi Kerasionalan Pengobatan Diabetes Melitus Tipe 2. Jurnal Kesehatan Bakti Tunas Husada, 17(1), 183–197
Tampa’i, R., Sumombo, J., Hariyadi, H., & Lengkey, Y. 2021. Gambaran Drug Related Problems (DRPs) pada Pasien Diabetes Melitus Tipe 2 di Puskesmas Tuminting. Jurnal Kefarmasian Indonesia, 11(1), 49–55.
Willer, A., Harreiter, J., & Pacini, G. 2016. Sex and Gender Differences In Risk, Pathophysiology and Complication ff Type 2 Diabetes Mellitus. Journal Endocrin Review, 278–316
Isnaini, N., & Ratnasari, R. 2018. Faktor risiko mempengaruhi kejadian Diabetes mellitus tipe dua. Jurnal Kebidanan Dan Keperawatan Aisyiyah, 14(1), 59–68
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 JOURNAL OF PHARMACY SCIENCE AND TECHNOLOGY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
